Novo Nordisk A/S | Novo Holdings A/S | kickbacks and bribery | 2009 | DOJ_CRIMINAL | $9,000,000 |
Novo Nordisk A/S | Novo Holdings A/S | Foreign Corrupt Practices Act | 2009 | SEC | $9,030,149 |
Novo Nordisk Inc. | Novo Holdings A/S | False Claims Act and related | 2017 | DOJ_CIVIL | $58,650,000 |
Novo Nordisk Inc. | Novo Holdings A/S | False Claims Act and related | 2011 | USAO | $1,725,000 |
Novo Nordisk Inc. | Novo Holdings A/S | False Claims Act and related | 2017 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $3,320,963 |
Novo Nordisk Inc. | Novo Holdings A/S | off-label or unapproved promotion of medical products | 2011 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $3,574,209 |
Novo Nordisk Inc. | Novo Holdings A/S | off-label or unapproved promotion of medical products | 2017 | CA-INS | $1,100,000 |
Novo Nordisk Pharmaceutical Industries, Inc. | Novo Holdings A/S | environmental violation | 2009 | NC-ENV | $36,836 |
Novo Nordisk Inc | Novo Holdings A/S | False Claims Act and related | 2022 | USAO | $6,300,000 |
Novo Nordisk A/S | Novo Holdings A/S | price-fixing or anti-competitive practices | 2015 | private lawsuit-federal | $19,000,000 |
NOVOZYMES BIOLOGICALS, INC. | Novo Holdings A/S | workplace safety or health violation | 2003 | OSHA | $5,610 |
NOVOZYMES BIOLOGICALS, INC | Novo Holdings A/S | environmental violation | 2009 | EPA | $26,797 |
NOVOZYMES BIOLOGICALS, INC. | Novo Holdings A/S | environmental violation | 2016 | EPA | $8,400 |
NOVO NORDISK BIOCHEM, N.A., INC. | Novo Holdings A/S | environmental violation | 2000 | EPA | $5,000 |
Mia Rose, Inc. | Nutraceutical International Corp. | environmental violation | 2014 | CA-ARB | $45,000 |
Omeros Corporation | Omeros Corp. | False Claims Act and related | 2012 | private lawsuit-federal | $3,940,000 |
Organon | Organon & Co. | off-label or unapproved promotion of medical products | 2014 | MULTI-AG | $31,000,000 |
Organon USA Inc | Organon & Co. | price-fixing or anti-competitive practices | 2004 | MULTI-AG | $36,000,000 |
Organon USA Inc. | Organon & Co. | drug or medical equipment safety violation | 2018 | private lawsuit-federal | $100,000,000 |
Organon Inc. | Organon & Co. | price-fixing or anti-competitive practices | 2005 | private lawsuit-federal | $75,000,000 |
Otsuka American Pharmaceutical Inc. | Otsuka Pharmaceutical | off-label or unapproved promotion of medical products | 2008 | FDA | $4,000,000 |
Pharmavite LLC | Otsuka Pharmaceutical | wage and hour violation | 2017 | private lawsuit-state | $1,925,000 |
Otsuka America Pharmaceutical, Inc. | Otsuka Pharmaceutical | consumer protection violation | 2007 | VT-AG | $10,000 |
Otsuka American Pharmaceutical Inc. | Otsuka Pharmaceutical | off-label or unapproved promotion of medical products | 2008 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $1,700,000 |
Avanir Pharmaceuticals | Otsuka Pharmaceutical | False Claims Act and related | 2019 | DOJ_CIVIL | $115,874,895 |
Avanir Pharmaceuticals | Otsuka Pharmaceutical | False Claims Act and related | 2019 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $7,000,000 |
Pharmavite LLC | Otsuka Pharmaceutical | consumer protection violation | 2017 | private lawsuit-federal | $10,975,000 |
Otsuka American Pharmaceutical Inc | Otsuka Pharmaceutical | wage and hour violation | 2018 | MI-LEO | $12,500 |
Otsuka American Pharmaceutical Inc | Otsuka Pharmaceutical | wage and hour violation | 2018 | MI-LEO | $5,070 |
PHARMAVITE CORP | Otsuka Pharmaceutical | workplace safety or health violation | 2001 | OSHA | $18,300 |
PHARMAVITE | Otsuka Pharmaceutical | workplace safety or health violation | 2005 | OSHA | $20,055 |
PHARMAVITE LLC | Otsuka Pharmaceutical | workplace safety or health violation | 2019 | OSHA | $5,775 |
Pacira Pharmaceuticals, Inc. | Pacira BioSciences | kickbacks and bribery | 2020 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $3,500,000 |
Pacira Pharmaceuticals Inc. | Pacira BioSciences | False Claims Act and related | 2020 | USAO | $3,500,000 |
Parexel International, LLC | Parexel International | labor relations violation | 2012 | NLRB | $253,000 |
ExecuPharm, Inc. | Parexel International | Family and Medical Leave Act | 2017 | WHD | $5,900 |
Elan Corporation PLC | Perrigo | off-label or unapproved promotion of medical products | 2010 | FDA | $203,000,000 |
Perrigo Company | Perrigo | price-fixing or anti-competitive practices | 2004 | FTC | $3,750,000 |
Elan Corporation, plc | Perrigo | accounting fraud or deficiencies | 2005 | SEC | $15,000,000 |
Perrigo Company | Perrigo | Family and Medical Leave Act | 2014 | WHD | $15,022 |
Elan Pharmaceuticals Inc. | Perrigo | export control violation | 2005 | BIS | $31,000 |
Elan Corp. | Perrigo | off-label or unapproved promotion of medical products | 2010 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $43,399,040 |
Perrigo | Perrigo | False Claims Act and related | 2013 | LA-AG | $2,000,000 |
Perrigo Company | Perrigo | price-fixing or anti-competitive practices | 2004 | MULTI-AG | $750,000 |
Perrigo Company | Perrigo | employment discrimination | 2021 | NY-NYCCHR | $20,000 |
Perrigo Co. | Perrigo | consumer protection violation | 2022 | CA-MULTI | $360,000 |
ELAN PHARMACEUTICALS INC. | Perrigo | workplace safety or health violation | 2003 | OSHA | $7,125 |
ELAN PHARMACEUTICALS INC. | Perrigo | workplace safety or health violation | 2004 | OSHA | $18,225 |
PERRIGO COMPANY OF SOUTH CAROLINA | Perrigo | workplace safety or health violation | 2008 | OSHA | $5,000 |
PBM NUTRITIONALS LLC | Perrigo | workplace safety or health violation | 2021 | OSHA | $14,502 |
PERRIGO COMPANY PLC | Perrigo | workplace safety or health violation | 2023 | OSHA | $12,600 |
King Pharmaceuticals LLC | Pfizer | environmental violation | 2013 | EPA | $2,200,000 |
Wyeth Pharmaceuticals Inc. | Pfizer | off-label or unapproved promotion of medical products | 2013 | FDA | $490,900,000 |
Pfizer Inc. | Pfizer | drug or medical equipment safety violation | 2012 | FDA | $55,000,000 |
Pfizer Inc. | Pfizer | off-label or unapproved promotion of medical products | 2011 | FDA | $14,500,000 |
Pfizer Pharmaceuticals LLC | Pfizer | environmental violation | 2014 | EPA | $728,000 |
Pfizer H.C.P. Corporation | Pfizer | Foreign Corrupt Practices Act | 2012 | DOJ_CRIMINAL | $15,000,000 |
Pfizer Inc. | Pfizer | Foreign Corrupt Practices Act | 2012 | SEC | $26,339,944 |
Wyeth LLC | Pfizer | Foreign Corrupt Practices Act | 2012 | SEC | $18,876,624 |
Pfizer Inc. | Pfizer | False Claims Act and related | 2016 | DOJ_CIVIL | $784,600,000 |
Alpharma Inc. | Pfizer | False Claims Act and related | 2010 | DOJ_CIVIL | $42,500,000 |
Alpharma, Inc. | Pfizer | price-fixing or anti-competitive practices | 2004 | FTC | $2,500,000 |
Pfizer Inc. | Pfizer | off-label or unapproved promotion of medical products | 2009 | FDA | $2,300,000,000 |
King Pharmaceuticals | Pfizer | False Claims Act and related | 2005 | DOJ_CIVIL | $124,000,000 |
Warner-Lambert | Pfizer | off-label or unapproved promotion of medical products | 2004 | FDA | $430,000,000 |
Pfizer Corporation | Pfizer | False Claims Act and related | 2002 | DOJ_CIVIL | $49,000,000 |
Pfizer Inc. | Pfizer | environmental violation | 2008 | EPA | $975,000 |
Hospira Inc. | Pfizer | employment discrimination | 2015 | OFCCP | $400,000 |
Wyeth Biopharma | Pfizer | wage and hour violation | 2005 | WHD | $40,187 |
Pfizer Inc. | Pfizer | railroad safety violation | 2002 | FRA | $11,250 |
Pharmacia & Upjohn Company Inc. | Pfizer | kickbacks and bribery | 2007 | USAO | $19,700,000 |
Pharmacia & Upjohn Company LLC | Pfizer | kickbacks and bribery | 2007 | USAO | $15,000,000 |
Pfizer, Inc. | Pfizer | False Claims Act and related | 2018 | DOJ_CIVIL | $23,850,000 |
Seagen Pharmaceuticals, Inc. | Pfizer | benefit plan administrator violation | 2001 | EBSA | $29,974 |
Pfizer | Pfizer | employment discrimination | 2009 | private lawsuit-federal | $1,365,003 |
Wyeth | Pfizer | benefit plan administrator violation | 2013 | private lawsuit-federal | $2,000,000 |
Alpharma Inc. | Pfizer | False Claims Act and related | 2010 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $8,900,000 |
Alpharma, Inc. | Pfizer | price-fixing or anti-competitive practices | 2004 | MULTI-AG | $750,000 |
King Pharmaceuticals | Pfizer | False Claims Act and related | 2006 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $124,000,000 |
Pfizer | Pfizer | drug or medical equipment safety violation | 2003 | MULTI-AG | $6,000,000 |
Pfizer | Pfizer | off-label or unapproved promotion of medical products | 2014 | MULTI-AG | $35,000,000 |
Pfizer | Pfizer | consumer protection violation | 2019 | OR-AG | $975,000 |
Pfizer Inc. | Pfizer | False Claims Act and related | 2002 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $21,084,700 |
Pfizer Inc. | Pfizer | False Claims Act and related | 2011 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $2,621,154 |
Pfizer Inc. | Pfizer | off-label or unapproved promotion of medical products | 2008 | MULTI-AG | $60,000,000 |
Pfizer Inc. | Pfizer | off-label or unapproved promotion of medical products | 2013 | MA-AG | $375,000 |
Pfizer Inc. | Pfizer | False Claims Act and related | 2013 | TX-AG | $18,170,000 |
Pfizer Inc. and Pharmacia Corp. | Pfizer | False Claims Act and related | 2012 | ID-AG | $2,900,000 |
Pfizer Inc. | Pfizer | off-label or unapproved promotion of medical products | 2012 | MULTI-AG | $42,900,000 |
Pfizer Inc. | Pfizer | consumer protection violation | 2018 | NY-AG | $700,000 |
Pfizer, Inc. | Pfizer | kickbacks and bribery | 2009 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $331,485,170 |
Pfizer, Inc. | Pfizer | drug or medical equipment safety violation | 2012 | OR-AG | $3,340,000 |
Pfizer, Inc. and Pharmacia Corporation | Pfizer | False Claims Act and related | 2010 | HI-AG | $8,200,000 |
Pharmacia Corp. | Pfizer | False Claims Act and related | 2009 | OH-AG | $400,000 |
Pharmacia Corporation | Pfizer | False Claims Act and related | 2011 | NY-AG | $2,500,000 |
Pharmacia Corporation | Pfizer | False Claims Act and related | 2013 | WI-AG | $29,453,247 |
Purepac Pharmaceutical Co. | Pfizer | False Claims Act and related | 2010 | ID-AG | $600,000 |
Purepac Pharmaceutical Co., n/k/a Actavis Elizabeth, LLC | Pfizer | False Claims Act and related | 2011 | MS-AG | $2,010,667 |
Warner-Lambert | Pfizer | off-label or unapproved promotion of medical products | 2004 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $190,000,000 |
Wyeth Pharmaceuticals, Inc. | Pfizer | False Claims Act and related | 2016 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $371,351,180 |
Wyeth Pharmaceuticals, Inc. | Pfizer | off-label or unapproved promotion of medical products | 2013 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $257,400,000 |